| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.027 | 0.9 |